Hepatocellular Carcinoma in Patients With Cryptogenic Cirrhosis

Clinical Gastroenterology and Hepatology

Volumn 7, Issue 5, 2009, Pages 580-585

  Giannini, Edoardo Giovanni ^a   Marabotto, Elisa ^a   Savarino, Vincenzo ^a   Trevisani, Franco ^b   di Nolfo, Maria Anna ^c   Poggio, Paolo Del ^d   Benvegnù, Luisa ^e   Farinati, Fabio ^e   Zoli, Marco ^b   Borzio, Franco ^f   Caturelli, Eugenio ^g   Chiaramonte, Maria ^h  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c BOLOGNINI HOSPITAL   (Italy)

^d TREVIGLIO HOSPITAL   (Italy)

^e UNIVERSITY OF PADOVA   (Italy)

^f FATEBENEFRATELLI HOSPITAL   (Italy)

^g BELCOLLE HOSPITAL   (Italy)

^h UNIVERSITY OF L'AQUILA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE;

ADULT; AGED; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CANCER RISK; CANCER SURVIVAL; CLINICAL ARTICLE; COMPARATIVE STUDY; DISEASE ASSOCIATION; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MALE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; FEMALE; HEPATITIS, CHRONIC; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PLATELET COUNT; TRANSAMINASES;

EID: 67349157155     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2009.01.001     Document Type: Article

References (29)

1. Benvegnù L., Gios M., Boccato S., et al. Natural history of compensated viral cirrhosis: a prospective study on the incidence and hierarchy of major complications. Gut 53 (2004) 744-749
2. Sangiovanni A., Prati G.M., Fasani P., et al. The natural history of compensated cirrhosis due to hepatitis C virus: a 17-year cohort study of 214 patients. Hepatology 43 (2006) 1303-1310
3. Talwalkar J.A., and Kamath P.S. Influence of recent advances in clinical management on clinical outcomes of cirrhosis. Mayo Clin Proc 80 (2005) 1501-1508
4. Yuen M.F., Cheng C.C., Lauder I.J., et al. Early detection of hepatocellular carcinoma increases the chance of treatment: Hong Kong experience. Hepatology 31 (2000) 330-335
5. Bolondi L., Sofia S., Siringo S., et al. Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis. Gut 48 (2001) 251-259
6. Trevisani F., De Notariis S., Rapaccini G., et al. Semiannual and annual surveillance of cirrhotic patients for hepatocellular carcinoma: effects on cancer stage and patient survival (Italian experience). Am J Gastroenterol 97 (2002) 734-744
7. Sangiovanni A., Del Ninno E., Fasani P., et al. Increased survival of cirrhotic patients with a hepatocellular carcinoma detected during surveillance. Gastroenterology 126 (2004) 1005-1014
8. Caldwell S.H., Oelsner D.H., Iezzoni J.C., et al. Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease. Hepatology 29 (1999) 664-669
9. Farrell G.C., and Larter C.Z. Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology 43 Suppl 1 (2006) S99-S112
10. Ayata G., Gordon F.D., Lewis W.D., et al. Cryptogenic cirrhosis: clinicopathologic findings at and after liver transplantation. Hum Pathol 33 (2002) 1098-1104
11. Bugianesi E., Leone N., Vanni E., et al. Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology 123 (2002) 134-140
12. Marrero J.A., Fontana R.J., Su G.L., et al. NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States. Hepatology 36 (2002) 1349-1354
13. Ratziu V., Bonyhay L., Di Martino V., et al. Survival, liver failure, and hepatocellular carcinoma in obesity-related cryptogenic cirrhosis. Hepatology 35 (2002) 1485-1493
14. Hui J.M., Kench J.G., Chitturi S., et al. Long-term outcomes of cirrhosis in nonalcoholic steatohepatitis compared with hepatitis C. Hepatology 38 (2003) 420-427
15. Adams L.A., Lymp J.F., St Sauver J., et al. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology 129 (2005) 113-121
16. Commissione "Epatocarcinoma" dell'Associazione Italiana per lo Studio del Fegato. Epatocarcinoma: linee guida per la diagnosi e la terapia (1998), Tipografia Moderna, Bologna 235-268
17. Pugh R.N., Murray-Lyon I.M., Dawson J.L., et al. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 60 (1973) 646-649
18. Mazzaferro V., Regalia E., Doci R., et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 334 (1996) 693-699
19. Giannini E.G., Risso D., Testa R., et al. Prevalence and prognostic significance of the presence of esophageal varices in patients with hepatocellular carcinoma. Clin Gastroenterol Hepatol 4 (2006) 1378-1384
20. Trevisani F., Santi V., Gramenzi A., et al. Surveillance for early diagnosis of hepatocellular carcinoma: is it effective in intermediate/advanced cirrhosis?. Am J Gastroenterol 102 (2007) 2448-2457
21. Bruix J., and Sherman M. Management of hepatocellular carcinoma. Hepatology 42 (2005) 1208-1236
22. Bosch F.X., Ribes J., Clèries M., et al. Epidemiology of hepatocellular carcinoma. Clin Liver Dis 9 (2005) 191-211
23. El-Serag H.B., and Mason A.C. Risk factors for the rising rates of primary liver cancer in the United States. Arch Intern Med 160 (2000) 3227-3230
24. Ong J.P., and Younossi Z.M. Is hepatocellular carcinoma part of the natural history of nonalcoholic steatohepatitis?. Gastroenterology 123 (2002) 375-378
25. Bugianesi E. Non-alcoholic steatohepatitis and cancer. Clin Liver Dis 11 (2007) 191-207
26. Stroffolini T., Andreone P., Andriulli A., et al. Characteristics of hepatocellular carcinoma in Italy. J Hepatol 29 (1998) 944-952
27. Wong L.L., Limm W.M., Severino R., et al. Improved survival with screening for hepatocellular carcinoma. Liver Transplant 6 (2000) 320-325
28. Sherman S. Surveillance for hepatocellular carcinoma and early diagnosis. Clin Liver Dis 11 (2007) 817-837
29. Concato J., Feinstein A.R., and Holford T.R. The risk of determining risk with multivariable models. Ann Intern Med 118 (1993) 201-210